FFLG Fidelity Fundamental Large Cap Growth ETF
Profitability Metrics
Valuation Metrics
Growth & Cash Flow
Price Change
Top 10 Holdings
| Stock Ticker | Weight |
|---|---|
| NVDA | 13.64% |
| NA | 10.87% |
| AAPL | 7.46% |
| GOOGL | 5.66% |
| AMZN | 4.90% |
| MSFT | 4.33% |
| LLY | 2.84% |
| META | 2.68% |
| AVGO | 2.46% |
| TSM | 2.32% |
ETF Analysis
Fund Overview
Fidelity Fundamental Large Cap Growth ETF (FFLG) currently reports 93 stock positions (subject to change), placing it in the diversified without being diffuse range by holdings breadth. The top line-up is NVDA (13.64%), NA (10.87%), AAPL (7.46%), with NVDA as the largest single weight at 13.64%. Together, the top three holdings account for 31.97%, which represents a dominant share and increases sensitivity to the performance of a narrow leadership group. Taken together, the portfolio's structure reflects a deliberate trade-off between conviction at the top and risk spreading across the broader holding set.
Profitability & Capital Efficiency
On a capital return basis, ROIC is 41.74%, WACC is 12.35%, and the economic spread is 29.39%. On balance, the portfolio's businesses are compounding at rates that meaningfully exceed what capital costs would otherwise allow. Supporting metrics show ROE at 69.54% and ROA at 16.61%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.
Valuation
On an earnings multiple basis, trailing P/E of 11.78, forward P/E of 24.85, PEG of 2.30. The gap between trailing and forward multiples is not especially wide, suggesting the market is pricing a steadier earnings path rather than a sharp near-term re-rating. The PEG ratio sits in a range that most investors would consider fair — neither cheap nor obviously stretched relative to anticipated earnings. A current ratio of 2.31 suggests the holdings have sufficient short-term liquidity without excess. Combining multiples and liquidity, the portfolio appears adequately priced for its current earnings trajectory, with balance sheet health providing a degree of downside resilience.
Margins & Cash Generation
Stripping to unit economics, gross margin sits at 47.82%, operating margin at -1.57%, and free cash flow margin at 27.11%. Gross margins are healthy, suggesting solid pricing power across the underlying holdings. At this operating margin level, businesses are generating little to no earnings after overhead — a sign of early-stage or high-investment dynamics. The portfolio's free cash flow margin is exceptional, pointing to capital-light businesses with strong reinvestment optionality. Across the three margin layers, the picture is inconsistent — a reminder that aggregate metrics can mask meaningful variation at the individual holding level.
Growth & Forward Outlook
Connecting operational trends with market expectations, TTM revenue growth of 41.19% indicating strong organic momentum at the portfolio level, while the estimated 12-month price change of 21.58%, where consensus targets suggest reasonable upside rather than a step-change rerating. At -52.6%, the projected 12-month EPS growth is a notable negative — it suggests earnings headwinds are building, a dynamic that usually invites multiple compression rather than expansion. Operating momentum and analyst expectations are related but distinct — the former is backward-looking by nature, the latter inherently speculative. Against that backdrop, the more durable question is whether operating trends can be sustained long enough for analyst expectations to be validated. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.
Conclusion
BuyOverall, the fundamentals support a constructive stance — execution remains the key driver of whether the forward case is fully validated.
The views expressed above are derived from quantitative data only and should not be relied upon as financial advice. Investment decisions should be based on your own research and risk tolerance.